Chemomab Therapeutics Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $43.1M
Liabilities Breakdown FY2022
Total Liabilities: $6.8M
Asset Breakdown
Total Assets: $43.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $13.5M | 31.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $367.0K | 0.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $29.2M | 67.8% |
Liabilities Breakdown
Total Liabilities: $6.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 24.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.2M | 75.3% |